BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health [Yahoo! Finance]